Fig. 4From: Immunosuppressive therapy for progressive idiopathic membranous nephropathy: a cost-effectiveness analysis in ChinaIncremental cost-effectiveness scatter plot of probabilistic sensitivity analysis (the slope of WTP $12,044/QALY)Back to article page